B. Alcaide, P. Almendros et al.
extract was washed with brine, dried (MgSO4), and concentrated under
reduced pressure. Chromatography of the residue with ethyl acetate/
hexane (1:3) as the eluent gave 16 as a colorless oil (16 mg, 35%).
acetate (1:1) as the eluent (+)-19b was obtained as a colorless oil (25 mg,
50%). [a]D =+1.2 (c=0.8 in CHCl3); H NMR (300 MHz, CDCl3, 258C):
1
d=8.08 and 6.96 (d, each 2H, J=9.0 Hz), 7.24 (m, 5H), 5.84 (m, 1H),
5.57 (d, 1H, J=5.0 Hz), 4.58 and 4.42 (d, each 1H, J=11.5 Hz), 4.21 (m,
1H), 4.08 (dd, 1H, J=8.0, 5.0 Hz), 3.89 (s, 3H), 3.87 (dd, 1H, J=12.2,
3.0 Hz), 3.66 (dd, 1H, J=11.9, 5.0 Hz), 2.90 (d, 2H, J=7.0 Hz), 1.44 ppm
(s, 3H); 13C NMR (75 MHz, CDCl3, 258C): d=165.6, 163.7, 150.8, 137.5,
136.4, 131.8, 128.3, 127.9, 127.8, 122.1, 116.7, 113.8, 111.3, 86.4, 80.3, 77.3,
1
Dihydropyran 2: H NMR (300 MHz, CDCl3, 258C): d=8.02 and 6.90 (d,
each 2H, J=9.0 Hz), 6.26 (s, 1H), 5.18 (s, 2H), 3.86 (s, 3H), 2.22 (br s,
3H), 1.94 ppm (brs, 3H); IR (CHCl3): n˜ =1725 cmÀ1; ES-MS: m/z (%):
275 (100) [M+H]+, 274 (11) [M]+.
General procedure for the PdII-catalyzed cyclization of allenic diols 3
and 4 in the presence of allyl bromide: Preparation of dihydropyrans 17,
tetrahydrooxepines 18, and tetrahydrofuran (+)-19b. Palladium(II) chlo-
ride (0.005 mmol) was added to a stirred solution of the corresponding al-
lenic diol 3 and 4 (0.10 mmol) and allyl bromide (0.50 mmol) in DMF
(0.6 mL). The reaction was stirred in an argon atmosphere until disap-
pearance of the starting material (TLC). Water (0.5 mL) was added to
the reaction mixture, which was extracted with ethyl acetate (3ꢃ4 mL).
The organic phase was washed with water (2ꢃ2 mL), dried (MgSO4), and
concentrated under reduced pressure. Chromatography of the residue
with hexane/ethyl acetate as the eluent gave analytically pure adducts
17–19.
74.8, 73.0, 62.9, 55.5, 36.2, 22.0 ppm; IR (CHCl3): n˜ =3436, 1724 cmÀ1
;
HRMS (ES): m/z: m/z: calcd for C26H31O6: 439.2121 [M+H]+; found:
439.2118.
General procedure for the PdII-catalyzed cyclization of allenic diols 3 in
the presence of lithium bromide: Preparation of dihydropyrans 20 or tet-
rahydrofurans 21: Palladium(II) acetate (0.01 mmol), lithium bromide
(0.74 mmol), potassium carbonate (0.18 mmol), and copper(II) acetate
(0.32 mmol) were added sequentially to a stirred solution of the corre-
sponding b,g-allendiol 3 (0.15 mmol) in acetonitrile (5 mL). The resulting
suspension was stirred at room temperature in an oxygen atmosphere
until the disappearance of the starting material (TLC). The organic phase
was diluted with brine (2 mL), extracted with ethyl acetate (3ꢃ5 mL),
washed with brine (2 mL), dried (MgSO4), and concentrated under re-
duced pressure. Chromatography of the residue with hexane/ethyl acetate
as the eluent gave analytically pure adducts 20 and 21.
Dihydropyran (+)-17a: Prepared from b,g-allendiol (À)-3a (75 mg,
0.27 mmol), and after chromatography of the residue with hexane/ethyl
acetate (4:1) as the eluent (+)-17a was obtained as a colorless oil (76 mg,
65%). [a]D =+21.9 (c=1.1 in CHCl3); 1H NMR (300 MHz, CDCl3,
258C): d=8.02 and 6.94 (d, each 2H, J=9.0 Hz), 5.74 (m, 1H), 5.61 (d,
1H, J=7.8 Hz), 5.11 (dd, 1H, J=9.3, 1.7 Hz), 5.04 (t, 1H, J=1.8 Hz),
4.16 (m, 2H), 3.88 (s, 3H), 3.68 (m, 3H), 2.87 and 2.68 (dd, each 1H, J=
15.5, 6.0 Hz), 1.67 ppm (brs, 3H); 13C NMR (75 MHz, CDCl3, 258C): d=
166.7, 163.2, 134.0, 132.0, 131.9, 125.6, 121.9, 116.0, 113.7, 77.2, 68.3, 67.8,
62.4, 55.5, 33.2, 13.4 ppm; IR (CHCl3): n˜ =3420, 1720 cmÀ1; HRMS (ES):
m/z: calcd for C18H22O5: 318.1467 [M+]; found: 318.1459.
Dihydropyran (+)-20a: Prepared from b,g-allendiol (À)-3a (100 mg,
0.36 mmol), and after chromatography of the residue with hexane/ethyl
acetate (3:1) as the eluent (+)-20a was obtained as a colorless oil (68 mg,
1
53%). [a]D =+3.5 (c=1.0 in CHCl3); H NMR (300 MHz, CDCl3, 258C):
d=8.07 and 6.95 (d, each 2H, J=9.0 Hz), 5.71 (m, 1H), 4.34 (m, 2H),
3.89 (s, 3H), 3.72 (m, 3H), 1.84 ppm (d, 3H, J=1.0 Hz); 13C NMR
(75 MHz, CDCl3, 258C): d=163.9, 164.0, 132.3, 132.0, 130.6, 119.7, 113.7,
77.3, 70.3, 68.7, 62.0, 55.5, 17.5 ppm; IR (CHCl3): n˜ =3425, 1716 cmÀ1
;
Dihydropyran (À)-17b: Prepared from b,g-allendiol (À)-3b (50 mg,
0.14 mmol), and after chromatography of the residue with hexane/ethyl
acetate (3:1) as the eluent (À)-17b was obtained as a colorless oil
(42 mg, 78%). [a]D =À15.2 (c=1.4 in CHCl3); 1H NMR (CDCl3): d=
7.69 and 6.80 (d, each 2H, J=9.0 Hz), 7.22 (m, 5H), 5.93 (brs, 1H), 5.69
(m, 1H), 5.05 (m, 2H), 4.41 and 4.28 (dd, each 1H, J=16.0, 2.0 Hz), 3.82
(s, 3H), 3.76 (m, 3H), 2.72 ppm (d, 2H, J=6.3 Hz); 13C NMR (CDCl3):
d=166.3, 163.5, 136.8, 134.9, 132.0, 131.6, 128.7, 128.3, 128.1, 127.2, 121.8,
116.6, 113.5, 77.4, 67.7, 67.4, 62.3, 55.4, 34.5 ppm; IR (CHCl3): n˜ =3424,
1715 cmÀ1; ES-MS : m/z (%): 380 (17) [M+], 379 (100) [M+À1].
HRMS (ES): m/z: calcd for C15H17BrO5: 356.0259 [M]+; found: 356.0268.
Dihydropyran (À)-20b: Prepared from b,g-allendiol (+)-3c (75 mg,
0.20 mmol), and after chromatography of the residue with hexane/ethyl
acetate (6:1) as the eluent (À)-20b was obtained as a colorless oil
(47 mg, 51%). [a]D =À22.8 (c=0.5 in CHCl3); 1H NMR (300 MHz,
CDCl3, 258C): d=7.72 (m, 4H), 7.32 (m, 6H), 4.14 (m, 3H), 3.72 (td,
1H, J=6.8, 3.1 Hz), 3.46 (dd, 1H, J=7.3, 3.2 Hz), 3.36 (dd, 1H, J=6.8,
5.1 Hz), 1.80 (brs, 3H), 1.06 ppm (s, 9H); 13C NMR (75 MHz, CDCl3,
258C): d=135.9, 135.8, 134.8, 133.3, 132.6, 130.0, 127.8, 127.7, 119.4, 79.5,
70.4, 68.9, 61.9, 27.1, 26.8, 19.8 ppm; IR (CHCl3): n˜ =3429 cmÀ1; EI-MS :
m/z (%): 461 (23) [M+], 443 (100).
Tetrahydrooxepine (À)-18a: Prepared from g,d-allendiol (À)-4aM
(76 mg, 0.19 mmol), and after chromatography of the residue with
hexane/ethyl acetate (1:1) as the eluent (À)-18a was obtained as a color-
Tetrahydrofuran (+)-21a: Prepared from b,g-allendiol (À)-3b (50 mg,
0.14 mmol), and after chromatography of the residue with hexane/ethyl
acetate (3:1) as the eluent (+)-21a (33 mg, 57%), which contained ap-
proximately 40% of its epimer as a colorless oil. The diastereoisomers of
21a are inseparable by column chromatography (the 1H and 13C NMR
data were obtained by analyzing the NMR spectra of the mixtures; how-
ever, the IR and MS spectroscopic data could not be assigned individual-
ly for them). [a]D =+5.9 (c=0.8 in CHCl3); 1H NMR (300 MHz, CDCl3,
258C): d=8.11 and 6.98 (d, each 0.8H, J=9.0 Hz), 7.61 (m, 2H), 7.40 (m,
3H), 6.59 and 5.80 (d, each 0.6H, J=2.0 Hz), 6.28 and 5.68 (d, each
0.4H, J=1.7 Hz), 6.12 (d, 0.4H, J=4.6 Hz), 5.29 (m, 0.6H), 4.67 (dd,
0.6H, J=12.4, 3.2 Hz,), 4.07 (m, 2H), 3.89 (s, 1.8H), 3.87 (m, 0.4H),
3.77 ppm (s, 1.2H); 13C NMR (75 MHz, CDCl3, 258C): d=164.0 (m),
163.9 (M), 163.3 (m), 163.2 (M), 150.4 (M+ m), 132.2 (M+ m), 128.5
(m), 128.4 (M+ m), 128.3 (M+ m), 128.2 (M), 127.8 (M+ m), 127.6
(M+ m), 126.3 (M), 126.2 (m), 113.8 (m), 113.3 (M), 88.1 (M+ m), 82.1
(M), 77.5 (m), 71.8 (m), 71.5 (M), 67.1 (m), 63.4 (M), 55.5 (M), 55.2 ppm
1
less oil (49 mg, 59%). [a]D =À1.5 (c=0.1 in CHCl3); H NMR (300 MHz,
CDCl3, 258C): d=8.05 and 6.90 (d, each 2H, J=9.0 Hz), 7.35 (s, 5H),
5.76 (m, 1H), 5.68 (d, 1H, J=3.6 Hz), 5.06 (m, 1H), 4.81 and 4.57 (d,
each 1H, J=11.6 Hz), 4.49 (dd, 1H, J=16.3, 1.9 Hz), 4.19 (dd, 1H, J=
16.3, 1.7 Hz), 3.87 (s, 3H), 3.84 (m, 1H), 3.66 (m, 2H), 3.51 (m, 1H), 2.78
(dd, 1H, J=15.6, 5.6 Hz), 2.62 (dd, 1H, J=15.6, 6.3 Hz), 1.93 ppm (s,
3H); 13C NMR (75 MHz, CDCl3, 258C): d=165.8, 163.4, 137.7, 134.5,
134.2, 131.7, 128.4, 128.1, 127.9, 122.8, 115.9, 113.7, 80.7, 79.3, 74.9, 73.5,
72.7, 63.9, 55.4, 35.3, 20.6 ppm; IR (CHCl3: n˜ =3431, 1728 cmÀ1; HRMS
(ES): m/z: calcd for C26H31O6: 439.2121 [M+H]+; found: 439.2124.
Tetrahydrooxepine (+)-18b: Prepared from g,d-allendiol (+)-4b (28 mg,
0.06 mmol), and after chromatography of the residue with hexane/ethyl
acetate (3:1) as the eluent (+)-18b was obtained as a colorless oil
(16 mg, 53%). [a]D =+2.0 (c=0.3 in CHCl3); 1H NMR (300 MHz,
CDCl3, 258C): d=7.99 and 6.93 (d, each 2H, J=9.0 Hz), 7.26 (m, 10H),
5.95 (d, 1H, J=2.1 Hz), 5.69 (m, 1H), 5.03 (m, 2H), 4.73 and 4.52 (d,
each 1H, J=11.3 Hz), 4.71 and 4.41 (d, each 1H, J=16.6 Hz), 3.88 (s,
3H), 3.82 (m, 2H), 3.71 and 3.56 (d, each 1H, J=11.9 Hz), 2.69 (dd, 1H,
J=15.0, 6.2 Hz), 2.59 ppm (dd, 1H, J=15.7, 6.5 Hz); 13C NMR (75 MHz,
CDCl3, 258C): d=165.4, 163.4, 142.3, 138.5, 137.5, 135.4, 134.0, 131.8,
128.5, 128.4, 128.3, 128.2, 127.4, 126.9, 116.6, 113.7, 81.0, 79.4, 74.5, 73.3,
72.6, 64.0, 55.5, 36.7 ppm; IR (CHCl3): n˜ =3430, 1725 cmÀ1; HRMS (ES):
m/z: calcd for C31H32NaO6: 523.2097 [M+Na]+; found: 523.2095.
(m); IR (CHCl3): n˜ =3435, 1718 cmÀ1; EI-MS : m/z (%): 420 (98) [M+
2], 418 (100) [M+].
+
Tetrahydrofuran (À)-21b: Prepared from b,g-allendiol (+)-3d (65 mg,
0.30 mmol), and after chromatography of the residue with hexane/ethyl
acetate (3:1) as the eluent (À)-21b was obtained as a colorless oil
(49 mg, 55%). [a]D =À26.3 (c=0.4 in CHCl3); 1H NMR (300 MHz,
CDCl3, 258C): d=7.52 (m, 2H), 7.37 (m, 3H), 6.26 and 5.70 (d, each 1H,
J=1.7 Hz), 4.30 (m, 2H), 3.99 (dd, 1H, J=9.5, 6.3 Hz,), 3.85 (dd, 1H, J=
9.5, 4.9 Hz), 3.74 (s, 3H), 3.48 ppm (d, 1H, J=6.8 Hz); 13C NMR
Tetrahydrofuran (+)-19b: Prepared from g,d-allendiol (À)-4am (46 mg,
0.12 mmol), and after chromatography of the residue with hexane/ethyl
13250
ꢂ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2010, 16, 13243 – 13252